Literature DB >> 27859670

Leprosy reactions in postelimination stage: the Bangladesh experience.

M R Mowla1, S Ara2, A F M Mizanur Rahman2, S P Tripura3, S Paul4.   

Abstract

BACKGROUND: Leprosy reactions are immunologically mediated conditions and a major cause of disability before, during and after multidrug therapy (MDT). Little data have been published on the epidemiology of leprosy reactions in Bangladesh.
OBJECTIVES: To describe the pattern and prevalence of leprosy reactions in the postelimination stage.
METHODS: A descriptive retrospective cross-sectional study was carried out in Chittagong Medical College Hospital using the registered records of patients in the period between 2004 and 2013.
RESULTS: Of the 670 patients with leprosy, 488 (73.38%) were males and 182 (27.37%) were females. The prevalence of reaction was in 300 (44.78%) patients with a male:female ratio of 3.55 : 1. The age-specific cumulative reaction cases at >40 years were 115 (38.33%) among all age groups. The prevalence of reaction was found to be in 166 (55.33%) patients for the reversal reaction, 49 (16.57%) for the erythema nodosum leprosum (ENL) and 85 (28.33%) for the neuritis. Borderline tuberculoid was most common (106, 35.33%)in the reversal reaction group, while lepromatous leprosy was most common (37, 12.33%) in ENL group. More than half of the patients (169, 56.33%) had reactions at the time of presentations, while 85 (28.33%) and 46 (15.33%) patients developed reaction during and after MDT, respectively. The reversal reaction group presented with ≥six skin lesions in 96 (57.83%) patients and ≥two nerve function impairments (NFIs) in 107 (64.46%) patients. The ENL was present chiefly as papulo-nodular lesions in 45 (91.84%) patients followed by pustule-necrotic lesions in four (8.16%), neuritis in 33 (67.35%), fever in 24 (48.98%), lymphadenitis in six (12.24%), arthritis in five (10.20%) and iritis in two (4.08%). Bacterial index ≥3 had been demonstrated in 34 (60.71%) patients in ENL group.
CONCLUSION: The incidence of leprosy reaction seemed to be more than three times common in borderline tuberculoid (52.33%) group than in lepromatous leprosy (14%) group. Reactions with NFI and disability still occur among multibacillary patients during and after MDT. Early detection and management of leprosy reaction are very important in preventing disability and deformity, and patients should be educated to undergo regular follow-up examinations. Developing reinforced new therapies to curb leprosy reactions is crucial for improving leprosy healthcare services.
© 2016 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27859670     DOI: 10.1111/jdv.14049

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  4 in total

1.  Leprosy patients with deformities at post-elimination stage: The Bangladesh experience.

Authors:  M R Mowla; D M Angkur; Z Hasan; M N Sultana; S Afrin; M S Akhter
Journal:  Skin Health Dis       Date:  2020-10-14

2.  Understanding leprosy reactions and the impact on the lives of people affected: An exploration in two leprosy endemic countries.

Authors:  Annisa Ika Putri; Kevin de Sabbata; Regitta I Agusni; Medhi Denisa Alinda; Joydeepa Darlong; Barbara de Barros; Stephen L Walker; Marjolein B M Zweekhorst; Ruth M H Peters
Journal:  PLoS Negl Trop Dis       Date:  2022-06-13

3.  Leprosy Reactions and Neuropathic Pain in Pure Neural Leprosy in a Reference Center in Rio de Janeiro - Brazil.

Authors:  Izabela Jardim Rodrigues Pitta; Mariana Andrea Hacker; Robson Teixeira Vital; Ligia Rocha Andrade; Clarissa Neves Spitz; Anna Maria Sales; Sergio Luiz Gomes Antunes; Euzenir Nunes Sarno; Marcia Rodrigues Jardim
Journal:  Front Med (Lausanne)       Date:  2022-03-25

Review 4.  Systematic Review of Survival Analysis in Leprosy Studies-Including the Following Outcomes: Relapse, Impairment of Nerve Function, Reactions and Physical Disability.

Authors:  Celivane Cavalcanti Barbosa; Gilberto Silva Nunes Bezerra; Amanda Tavares Xavier; Maria de Fátima Pessoa Militão de Albuquerque; Cristine Vieira do Bonfim; Zulma Maria de Medeiros; Wayner Vieira de Souza
Journal:  Int J Environ Res Public Health       Date:  2022-09-26       Impact factor: 4.614

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.